Effect of esomeprazole [Nexium] on the pharmacokinetics of BMS-275183 [oral taxane] in patients with advanced malignancies

Trial Profile

Effect of esomeprazole [Nexium] on the pharmacokinetics of BMS-275183 [oral taxane] in patients with advanced malignancies

Discontinued
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2007

At a glance

  • Drugs BMS 275183; Esomeprazole
  • Indications Cancer; Gastrointestinal disorders
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 03 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top